Arcreal
Latest round
- Seed
Last raised
- Oct 2022
Total raised
- $4.2M
Investors
- 5
About Arcreal
Based in Seoul, South Korea, and founded in 2021, Arcreal operates as a digital healthcare technology company that develops oral scanners, medical software, and dental platforms. The company is working on the digital transformation (DX) of the dental industry with IT technology, by developing intraoral scanners, medical software, and dental platforms, through 3D graphics, artificial intelligence (AI), and software engineering. The company will use the December 2025 funds to accelerate AI model development and establish a US branch as part of its expansion initiatives in the US and Europe.
Who invested in Arcreal
5 investors across 1 round
See all investors in Arcreal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 18, 2022
Amount
$4.2M
Investors
Questions about Arcreal
Who invested in Arcreal?
Arcreal has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arcreal raised?
Arcreal has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arcreal last raise money?
Arcreal's most recent round on record is a Seed, in Oct 2022.
What does Arcreal do?
Based in Seoul, South Korea, and founded in 2021, Arcreal operates as a digital healthcare technology company that develops oral scanners, medical software, and dental platforms.
Where is Arcreal headquartered?
Arcreal is headquartered in Seoul, South Korea.
Which VCs invest in companies like Arcreal?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at Arcreal's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Arcreal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.